Jonathan Sackier is listed as a director on 10 SEC Form D filings by 3 issuers between Jul 2011 and May 2015: HemoSonics, LLC (Charlottesville, VA — other health care — 2013; $15M reported sold to 34 investors), EpiEP, Inc. (New Haven, CT — other health care — 2011–2015; $13.4M reported sold to 55 investors) and NovaTract Surgical, Inc. (Madison, CT — other health care — 2012–2015; $3.2M reported sold to 13 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $31.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Jonathan Sackier and found 13 differences, 2 worth asking the sponsor about: Form D filed 158 days after the first sale; Jonathan Sackier is no longer listed on the Sep 23, 2015 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.